Just the FACTs 2024, Volume 5
President’s Letter
I hope you are all having exciting times over the summer or winter depending on where you live! On behalf of FACT, I am thrilled to let you know that FACT will publicly launch FACT Consulting’s Audit and Assessment Services to the cell and gene therapy industry. Since the first CAR-T product was commercialized in 2016, industry audit burden has been a focal point of multistakeholder deliberations and collaboration. Feedback from health care institutions, industry, professional organizations, and more have been woven into our processes to provide a valuable, sustainable, and credible solution that will refocus resources on patient care while promoting patient access to cell and gene therapies.
The adoption of our audit and assessment services will bring greater efficiency to this exciting field of medicine. As we like to say, it is a WIN-WIN-WIN solution because industry, health care institutions, and patients all benefit!!!
To drive adoption, we highlight two resources in this newsletter to help key opinion leaders propose the use of our service to their leadership:
- A brief, informative video that illustrates the highlights of the service in less than four minutes.
- A free webinar that features a discussion regarding our pilot assessment project and explains the value of these services to companies and audited sites alike.
Finally, please join us on September 17 as we celebrate Apheresis Awareness Day with ASFA! And wishing you all a very happy time in the sun or in the snow (or both)!
Sincerely,
Catherine Bollard, MD
FACT President
[Insert photos of Cath and Phyllis at ISCT ANZ]
